Sclerositis, in general, is an immune-related inflammatory condition, but can also have an infectious element of pathogens. Treatment varies depending on the type. In superficial sclerositis, most patients experience redness and mild pain in the eye, and the eye shows marked, deep conjunctival congestion with a dark red color; after exclusion of infectious factors and surface tissue breakdown, appropriate corticosteroid eye drops and ointments are needed For deep sclerositis, the inflammation invades the scleral stroma and is divided into anterior sclerositis and posterior sclerositis, using the equatorial region as a divider. posterior sclicitis. In particular, posterior sclicitis is relatively undetectable due to its deep location. The main manifestation is ocular pain, especially at night when the environment is quiet, and there is significant ciliary pressure pain when the eye is touched with a finger. Once diagnosed, the use of eye drops alone is not sufficient. Early oral administration of non-steroidal anti-inflammatory drugs as well as hormonal types of medications is usually required and can provide relief in most patients. Patients with concomitant systemic immune diseases also require immunosuppressive drugs. Sclerositis, which may be accompanied by other systemic immune system diseases, requires further investigation. Inadequate treatment can lead to complications, the most serious of which include: iritis, glaucoma, exudative retinal detachment, and scleral thinning resulting in scleral chylomicron. Scleral infection is a treatable disease, but it is prone to recurrence, so it is crucial to use medication as early as possible to avoid other eye complications.